Slate Hill, NY, United States of America

John M Peterson

This inventor holds 11 USPTO granted patents and 20 published patent applications, plus 5 CIPO patents and 4 EPO patents. Top assignees: Glycomimetics, Inc., Abb Technology Ag, Abb Research Ltd.. Active years: 2006-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John M Peterson. Retrieved from https://idiyas.com/inventor/john-m-peterson-sbqnwx6v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 20)

% Patents Active = 72.7

CIPO Patents = 5 (Patent Applications = 11)

EPO Patents = 4 (Patent Applications = 11)

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 24(Granted Patents)

Location History:

Jeffersonville, PA (US) (2006 - 2007)
Lansdale, PA (US) (2013)
Slate Hill, NY (US) (2019 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2006-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11878026 - Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists (2024-01-23),

2. 11873317 - Galectin-3 inhibiting c-glycosides (2024-01-16),

3. 11845771 - Heterobifunctional inhibitors of E-selectin and galectin-3 (2023-12-19),

4. 11780873 - Highly potent multimeric e-selectin antagonists (2023-10-10),

5. 11548908 - Heterobifunctional inhibitors of E-selectin and galectin-3 (2023-01-10),

6. 11197877 - Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists (2021-12-14),

7. 11072625 - Highly potent multimeric e-selectin antagonists (2021-07-27),

8. 10519181 - Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors (2019-12-31),

9. 8451574 - Method and system for through fault detection in electrical devices (2013-05-28),

10. 7272515 - Digital signal processor implementation of high impedance fault algorithms (2007-09-18),

11. 7085659 - Dynamic energy threshold calculation for high impedance fault detection (2006-08-01),

Title: The Innovations of John M Peterson

Introduction

John M Peterson is a notable inventor based in Slate Hill, NY (US). He holds an impressive portfolio of 11 patents, showcasing his contributions to the field of pharmaceutical sciences. His work primarily focuses on developing compounds and methods for treating various diseases and conditions.

Latest Patents

Among his latest patents are the "Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists." This patent discloses compounds, compositions, and methods for the treatment and prevention of diseases by inhibiting the binding of E-selectin to its ligands. Additionally, he has developed "Galectin-3 inhibiting c-glycosides," which describe compounds and methods for inhibiting the binding of galectin-3 to ligands, offering potential therapeutic benefits.

Career Highlights

Throughout his career, John M Peterson has worked with prominent companies such as Glycomimetics, Inc. and Abb Technology AG. His innovative approaches and dedication to research have significantly impacted the pharmaceutical industry.

Collaborations

John has collaborated with esteemed colleagues, including John L Magnani and Arun K Sarkar, further enhancing the scope and impact of his work.

Conclusion

John M Peterson's contributions to innovation in pharmaceuticals are noteworthy, with a strong focus on developing treatments for critical health issues. His extensive patent portfolio reflects his commitment to advancing medical science.

Profile summary based on public USPTO records.